Research use onlyNot for human or veterinary use
Encore Bio Labs CartExplore catalog
ENCORE BIO LABSRESEARCH COLLECTION
GHK-Cu — complete Encore Bio Labs reference vialMATERIAL / 08

Reference artwork · Legacy packaging may be shown.
Listed identity and formats take precedence over the image.

Research material

GHK-Cu

Discover the connection between copper peptides and the structures surrounding cells. GHK-Cu combines three amino acids with copper, and cell-culture studies examine its relationship with collagen production. A compact molecule with a clear research theme: the framework cells build around themselves.

CAS
89030-95-5

Formats & reference pricing

USD
Listed formatReference price
50 mg$50 USD
100 mg$70 USD

Reference prices describe the listed formats. They do not confirm availability or constitute an offer for sale.

Review product documentation

For laboratory research only. Not for human or veterinary use.

About the reference identity

Three amino acids and a copper complex

GHK stands for glycine, histidine and lysine, in that order. Cu identifies copper in the named complex. Chemical databases distinguish the peptide alone from the copper-containing record. The sequence is also different from AHK, whose first amino acid is alanine; the two names are not interchangeable.

Sequence shorthand
GHK · glycine–histidine–lysine
Name detail
Copper complex, distinct from the peptide alone

Reference identity only; not a test result for current inventory.

01 / Material overview

The specifications.

Catalog identity
GHK-Cu
CAS
89030-95-5
Listed formats
50 mg · 100 mg
Reference price range
$50–$70 USD
Intended setting
Qualified laboratory or institutional research
Inventory specifications
Independent inventory review pending

02 / Regulatory context

Regulatory & safety notes.

FDA’s public compounding materials can provide regulatory safety context. They do not verify a current Encore Bio Labs lot.

FDA PUBLIC RECORD · REVIEWED OCT 2026GHK-Cu

FDA compounding record · GHK-Cu

FDA states that compounded injectable drugs containing GHK-Cu may pose immunogenicity risk related to aggregation and peptide-related impurities and notes limited human data for safety-related considerations.

That FDA statement concerns compounded injectable drugs and does not establish the quality, safety, or suitability of this catalog material.

FDA record type
Human drug compounding safety context
Human-use guidance
Not provided

External public record

FDA · Bulk drug substances and potential safety risks

03 / Supporting records

Documentation.

Read the Encore summary, the scope of related reports and the status of privacy-redacted supplier copies.

No authenticated certificate establishing current-inventory identity or specifications is published for GHK-Cu in this catalog.

Encore documentary summary · not a laboratory-issued COA

View GHK-Cu PDF downloads ↓
Report availability
5 related reports located
Formats & scope
Related reports refer to 50 mg and 100 mg samples.
Report authenticity
Laboratory authentication pending
Inventory evidence review
Report-to-inventory correspondence has not been independently established. No purity, quantity or activity result is attributed to current inventory.
Outstanding review
Keep samples separate and clarify quantity discrepancies. Not every report measures net vial content.
Product-specific SDS
Not located in the reviewed PDF set; applicability and verification pending.

Document inventory reviewed October 6, 2026. Related reports were commissioned by third parties, not Encore. Original customer details and internal records are not included here.

Privacy-redacted supplier report

Supplier-provided laboratory report

Where prepared, these are copies redacted by Encore for privacy, not laboratory-issued public versions or Encore-commissioned tests. Analytical content is not replaced with Encore results.

GHK-Cu · Related reports

4 reports · PDF available

English original · 6 pages · 1.8 MB

Open PDF Download PDF

Spanish translation · 12 pages · 1.8 MB

Open Spanish PDF Download Spanish PDF

Open PDF uses a new tab. Download PDF saves the same privacy-redacted packet.

Prepared by Encore; not issued or certified by the laboratory. Each translated page is followed by its English source page, preserving original graphs and signatures. The separate English original is unchanged.

Included scope and exclusions: Selected reports name 50 mg and 100 mg samples. Not every report measures net vial content. A separate report labeled 100 mg gives 177 mg; that discrepancy remains unresolved and that report is excluded here.

Laboratory authentication pending. These related references are not independently authenticated certificates for current Encore inventory. Supplier confirmation does not resolve the scope or discrepancies listed above.

Copy preparation
5 source files in redacted review copies. Duplicate file formats are not additional tests.
Supplier sharing permission
Owner-confirmed for supplied reports; this does not imply a report exists for every product. Report authentication is a separate check.
Privacy review
Selected website copy redacted; residual identification risk remains. Retained references and copies elsewhere can still identify the original customer; redaction does not guarantee anonymity.
Downloads
Selected related-reference PDF available.
Laboratory-issued public copy
Not available. Encore-prepared redactions are not an issuer reissue.

Read the packet cover and each report’s scope and limitations. Outstanding review items above remain unresolved; PDF availability does not change verification status.

A public copy does not by itself verify current inventory. No laboratory replacement or delivery date is promised.

Explore summary & report status

04 / A closer look

Common questions.

01Which GHK-Cu formats and reference prices are listed?

50 mg: $50 USD; 100 mg: $70 USD. These are catalog quantities and reference prices, not usage instructions, stock confirmation or an offer for sale.

02Where can I find the GHK-Cu reports?

The Documentation section on this page includes Open PDF and Download PDF links to a 6-page English original containing 4 supplier-provided reports. Read the covered sample formats and limitations beside the download. These privacy-redacted, third-party-commissioned copies are not laboratory reissues. Laboratory authentication and independent inventory review remain pending.

03Does the image establish the contents of a lot?

No. The image is owned Encore Bio Labs reference artwork and may show legacy packaging. Use the written identity and specifications, then verify the exact lot with supporting records.

04How should research suitability be assessed?

Qualified personnel should evaluate material identity, lot-specific records, institutional requirements, and study design. Supplier-provided laboratory report. Independent inventory review remains pending, and no product-specific SDS was located in the reviewed set. This catalog provides no personal-use or preparation guidance.

Continue the collection

Next in the catalog.

View all materials